Junyi Hou

702 total citations
29 papers, 470 citations indexed

About

Junyi Hou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junyi Hou has authored 29 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junyi Hou's work include RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Junyi Hou is often cited by papers focused on RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Junyi Hou collaborates with scholars based in China, Hong Kong and Italy. Junyi Hou's co-authors include Liping Su, Bingya Liu, Xiongyan Wu, Zhenjia Yu, Zhenggang Zhu, Beiqin Yu, Chao Yan, Zhijian Jin, Jianfang Li and Tao Pan and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Junyi Hou

27 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyi Hou China 13 265 173 138 127 79 29 470
Baoen Shan China 15 296 1.1× 158 0.9× 173 1.3× 66 0.5× 67 0.8× 46 516
Jie Yao China 14 212 0.8× 120 0.7× 92 0.7× 168 1.3× 58 0.7× 51 488
Tasnuva D. Kabir Australia 9 291 1.1× 232 1.3× 75 0.5× 117 0.9× 65 0.8× 12 546
Pei Wu China 10 217 0.8× 122 0.7× 178 1.3× 100 0.8× 47 0.6× 33 505
Dengyan Zhu China 15 393 1.5× 301 1.7× 118 0.9× 102 0.8× 67 0.8× 32 605
Lin Zhong China 9 304 1.1× 220 1.3× 111 0.8× 221 1.7× 43 0.5× 21 523
Fangzhu Wan China 11 291 1.1× 186 1.1× 143 1.0× 55 0.4× 82 1.0× 17 492
Kaijing Wang China 13 177 0.7× 117 0.7× 87 0.6× 134 1.1× 42 0.5× 35 417
Mona Joudi Mashhad Iran 5 297 1.1× 176 1.0× 112 0.8× 99 0.8× 42 0.5× 7 550

Countries citing papers authored by Junyi Hou

Since Specialization
Citations

This map shows the geographic impact of Junyi Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Hou more than expected).

Fields of papers citing papers by Junyi Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Hou. The network helps show where Junyi Hou may publish in the future.

Co-authorship network of co-authors of Junyi Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi Hou. A scholar is included among the top collaborators of Junyi Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi Hou. Junyi Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yi, et al.. (2024). Unveiling the depths of pelvic organ prolapse: From risk factors to therapeutic methods (Review). Experimental and Therapeutic Medicine. 29(1). 11–11. 1 indexed citations
3.
Hou, Junyi, Peng Liu, Songbai Liu, et al.. (2024). TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells. Cellular Signalling. 120. 111227–111227. 4 indexed citations
4.
Hou, Junyi, Xiaodan Zhang, Guo-Wei Tu, et al.. (2024). Structural basis of antagonist selectivity in endothelin receptors. Cell Discovery. 10(1). 79–79. 3 indexed citations
5.
Feng, Haoran, Junxian Yu, Zhuoqing Xu, et al.. (2024). SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer. EBioMedicine. 109. 105375–105375. 6 indexed citations
6.
Zhu, Changhao, Peng Liu, Songbai Liu, et al.. (2024). PELI1: key players in the oncogenic characteristics of pancreatic Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 91–91. 5 indexed citations
7.
Yu, Junxian, Haoran Feng, Qingqing Sang, et al.. (2023). VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer. EBioMedicine. 89. 104451–104451. 15 indexed citations
8.
Li, Fangyuan, Junxian Yu, Tao Pan, et al.. (2023). BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C‐MYC/PLCG1/Perk Axis. Advanced Science. 10(34). e2303091–e2303091. 10 indexed citations
9.
Hou, Junyi, Xiongyan Wu, Yifan Lu, et al.. (2023). Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biology. 67. 102923–102923. 72 indexed citations
10.
Lu, Yifan, Zhijian Jin, Junyi Hou, et al.. (2022). Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. Matrix Biology. 115. 1–15. 53 indexed citations
11.
Shen, Yaxing, Junyi Hou, Youwen Chen, et al.. (2022). The effect of enhanced recovery after minimally invasive esophagectomy: a randomized controlled trial. Surgical Endoscopy. 36(12). 9113–9122. 13 indexed citations
12.
Fan, Zhiyuan, Beiqin Yu, Tao Pan, et al.. (2022). DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer. Translational Oncology. 27. 101577–101577. 1 indexed citations
13.
Sang, Qingqing, Wentao Dai, Junxian Yu, et al.. (2022). Identification of prognostic gene expression signatures based on the tumor microenvironment characterization of gastric cancer. Frontiers in Immunology. 13. 983632–983632. 1 indexed citations
14.
Li, Fangyuan, Jianfang Li, Junxian Yu, et al.. (2021). Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data. EBioMedicine. 69. 103436–103436. 16 indexed citations
15.
Zang, Mingde, Junyi Hou, Yakai Huang, et al.. (2021). Crocetin suppresses angiogenesis and metastasis through inhibiting sonic hedgehog signaling pathway in gastric cancer. Biochemical and Biophysical Research Communications. 576. 86–92. 21 indexed citations
16.
Jin, Zhijian, Yifan Lu, Xiongyan Wu, et al.. (2021). The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer. Redox Biology. 46. 102076–102076. 75 indexed citations
17.
Pan, Tao, Zhenjia Yu, Zhijian Jin, et al.. (2021). Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Molecular Therapy — Nucleic Acids. 23. 1288–1303. 31 indexed citations
18.
Wang, Xufeng, Xinyu Chang, Changyu He, et al.. (2021). ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK/AKT/MMP2 pathway. The FASEB Journal. 35(4). e20649–e20649. 23 indexed citations
19.
Huang, Qin, et al.. (2019). Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway. Cancer Cell International. 19(1). 291–291. 21 indexed citations
20.
Hou, Junyi, et al.. (2016). Identification of a prognostic 5-Gene expression signature for gastric cancer. Journal of Cancer Research and Clinical Oncology. 143(4). 619–629. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baoen Shan Breakdown of academic impact, for papers by Jie Yao Breakdown of academic impact, for papers by Tasnuva D. Kabir Breakdown of academic impact, for papers by Pei Wu Breakdown of academic impact, for papers by Dengyan Zhu Breakdown of academic impact, for papers by Lin Zhong Breakdown of academic impact, for papers by Fangzhu Wan Breakdown of academic impact, for papers by Kaijing Wang Breakdown of academic impact, for papers by Mona Joudi Mashhad
Rankless by CCL
2026